Simplifying Global Compliance
FDAnews Drug Daily Bulletin
ENANTA PHARMACEUTICALS ACHIEVES MILESTONE IN ALLIANCE WITH SHIONOGI & CO., LTD.
Dec. 21, 2005
Enanta Pharmaceuticals today announced that it has received a milestone payment
from its East Asia development and commercialization partner, Shionogi &
Co., Ltd., as Phase 2 studies have initiated in Japan for its community antibiotic,
EDP-420 (formerly known as EP-013420, and known in Japan as S-013420).
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing